SVNT off 73% – you can tell from the nondescript language in the PR header that the news is not good: Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference <a href="http://biz.yahoo.com/prnews/081027/ny41686.html" target="_blank">http://biz.yahoo.com/prnews/081027/ny41686.html</a>